Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Ovarian Epithelial

Explore clinical trials studying Carcinoma, Ovarian Epithelial. Study availability and eligibility vary by location and protocol.

532 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Ovarian Epithelial trial results

Recruiting

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

NCT06890338

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital /ID# 274793 Birmingham, Alabama, United States
  • Usa Mitchell Cancer Institute /ID# 276022 Mobile, Alabama, United States
  • University of California Los Angeles Medical Center /ID# 274566 Los Angeles, California, United States
  • Scripps Md Anderson - Prebys Cancer Center /ID# 276891 San Diego, California, United States
View all 67 locations
View Trial Details
Recruiting

Centralization and Oncologic Outcomes in Ovarian Cancer

NCT07075939

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, COVID-19, +30 more
Locations
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Razzini Carpi Carpi, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale di Mirandola Mirandola, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Pavullo nel Frignano Pavullo nel Frignano, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Civile Sassuolo Sassuolo, Modena, Italy
View Trial Details
Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

NCT07218809

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site La Jolla, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 299 locations
View Trial Details
Recruiting

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

NCT06915025

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • Advent Health Orlando, Florida, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
  • Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Recruiting

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT07702292

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Lombardy, Italy
  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore Roma, Italy
  • IRCCS Ospedale San Raffaele Milan, Segrate, Italy
View Trial Details
Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

NCT06819007

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Disney Family Cancer Center Burbank, California, United States
  • Scripps Clinic La Jolla, California, United States
  • Palo Alto Medical Foundation Palo Alto, California, United States
  • Broward Health Medical Center Fort Lauderdale, Florida, United States
View all 208 locations
View Trial Details
Recruiting

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

NCT05429970

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +32 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details

Related conditions